Nevro Stock Falls 17%
Shares of Nevro Corp. (NVRO), a medical device company, are losing 17 percent on Tuesday morning trade. Analysts at Truist Financial Co. lowered the stock's target price from $32.
Source: rttnews.com
Stay updated with breaking news from Owered Target. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Nevro Corp. (NVRO), a medical device company, are losing 17 percent on Tuesday morning trade. Analysts at Truist Financial Co. lowered the stock's target price from $32.